Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma.

scientific article published in April 2002

Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V8.I2.233
P932PMC publication ID4658357
P698PubMed publication ID11925598

P2093author name stringYan Zhao
Ning Zheng
Zhao-You Tang
Sheng-Long Ye
Rui-Xia Sun
P2860cites workDecrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive moleculesQ28360887
Suppression of tumourigenicity, and induction of differentiation of the canine mammary tumour cell line MCM-B2 by sodium phenylacetateQ31917919
Cells and cytokines in immunotherapy and gene therapy of cancerQ33635021
The potential for monocyte-mediated immunotherapy during infection and malignancy. Part I: apoptosis induction and cytotoxic mechanismsQ33647904
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience.Q33851968
Adoptive cellular therapy.Q33893656
Immunology and immunotherapy of human cancer: present concepts and clinical developmentsQ33899097
Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulinQ33915277
Recent advances in immunotherapy and monoclonal antibody treatment of cancerQ34126863
Current problems in the development of specific immunotherapeutic approaches to cancerQ34353885
Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferator-activated receptor gammaQ40805189
Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine.Q40888208
Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducersQ41740731
Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines.Q42827317
Suppression of immune surveillance in melanomaQ46831698
Discrimination between NK and LAK cytotoxic activities of murine spleen cells by MTT assay: differential inhibition by PGE(2) and EDTA.Q50510427
Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury.Q53994463
Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic.Q54357457
Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients.Q55481786
Effects of cryopreservation on immune responses. VIII. Enhanced secretion of interferon-gamma by frozen human peripheral blood mononuclear cellsQ57111200
Differential effect of cryopreservation on natural killer cell and lymphokine-activated killer cell activitiesQ57112802
LYMPHOKINE RELEASE FROM HUMAN LYMPHOMONONUCLEAR CELLS AFTER CO-CULTURE WITH ISOLATED PANCREATIC ISLETS: EFFECTS OF ISLET SPECIES, LONG-TERM CULTURE, AND MONOCYTE-MACROPHAGE CELL REMOVALQ57504397
T cells and tumoursQ59078519
Effect of intraportal adoptive immunotherapy on liver metastases after resection of pancreatic cancer.Q64970820
Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administrationQ67919757
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cellsQ68093747
The role of lipocortin I in macrophage-mediated immunosuppression in tumor-bearing miceQ68420492
The inhibition of lymphokine-activated killer cells in acute myeloblastic leukemia is mediated by transforming growth factor-beta 1Q70841051
Supplementation with selenium augments the functions of natural killer and lymphokine-activated killer cellsQ71541984
Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patientsQ71997948
Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cellsQ72130571
Phase I study of phenylacetate administered twice daily to patients with cancerQ72295048
Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumour cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinomaQ72664539
Role of function-associated molecules in target cell lysis: analysis of rat adherent lymphokine-activated killer cellsQ72676134
Biologic effects of the adoptive transfer of cells depleted of monocytes with L-phenylalanine methyl esterQ72722188
Comparison of the effects of immunosuppressive factors from newly established colon carcinoma cell cultures on human lymphocyte proliferation and cytokine secretionQ73281290
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectcryopreservationQ1144664
P304page(s)233-236
P577publication date2002-04-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleEffects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma
P478volume8

Reverse relations

cites work (P2860)
Q36178552Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application
Q42695574Construction of IL-2 gene-modified human hepatocyte and its cultivation with microcarrier
Q40697710DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line
Q30921046Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity
Q34668320The prognostic molecular markers in hepatocellular carcinoma

Search more.